Nov 13, 2024 Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update
Nov 11, 2024 Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia
Nov 6, 2024 Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024
Sep 16, 2024 Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial
Aug 27, 2024 Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys
Aug 14, 2024 Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update
Aug 12, 2024 Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial